Back to Course

2025 PACUPrep BCCCP Preparatory Course

0% Complete
0/0 Steps
  1. Pulmonary

    ARDS
    4 Topics
    |
    1 Quiz
  2. Asthma Exacerbation
    4 Topics
    |
    1 Quiz
  3. COPD Exacerbation
    4 Topics
    |
    1 Quiz
  4. Cystic Fibrosis
    6 Topics
    |
    1 Quiz
  5. Drug-Induced Pulmonary Diseases
    3 Topics
    |
    1 Quiz
  6. Mechanical Ventilation Pharmacotherapy
    5 Topics
    |
    1 Quiz
  7. Pleural Disorders
    5 Topics
    |
    1 Quiz
  8. Pulmonary Hypertension (Acute and Chronic severe pulmonary hypertension)
    5 Topics
    |
    1 Quiz
  9. Cardiology
    Acute Coronary Syndromes
    6 Topics
    |
    1 Quiz
  10. Atrial Fibrillation and Flutter
    6 Topics
    |
    1 Quiz
  11. Cardiogenic Shock
    4 Topics
    |
    1 Quiz
  12. Heart Failure
    7 Topics
    |
    1 Quiz
  13. Hypertensive Crises
    5 Topics
    |
    1 Quiz
  14. Ventricular Arrhythmias and Sudden Cardiac Death Prevention
    5 Topics
    |
    1 Quiz
  15. NEPHROLOGY
    Acute Kidney Injury (AKI)
    5 Topics
    |
    1 Quiz
  16. Contrast‐Induced Nephropathy
    5 Topics
    |
    1 Quiz
  17. Drug‐Induced Kidney Diseases
    5 Topics
    |
    1 Quiz
  18. Rhabdomyolysis
    5 Topics
    |
    1 Quiz
  19. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
    5 Topics
    |
    1 Quiz
  20. Renal Replacement Therapies (RRT)
    5 Topics
    |
    1 Quiz
  21. Neurology
    Status Epilepticus
    5 Topics
    |
    1 Quiz
  22. Acute Ischemic Stroke
    5 Topics
    |
    1 Quiz
  23. Subarachnoid Hemorrhage
    5 Topics
    |
    1 Quiz
  24. Spontaneous Intracerebral Hemorrhage
    5 Topics
    |
    1 Quiz
  25. Neuromonitoring Techniques
    5 Topics
    |
    1 Quiz
  26. Gastroenterology
    Acute Upper Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  27. Acute Lower Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  28. Acute Pancreatitis
    5 Topics
    |
    1 Quiz
  29. Enterocutaneous and Enteroatmospheric Fistulas
    5 Topics
    |
    1 Quiz
  30. Ileus and Acute Intestinal Pseudo-obstruction
    5 Topics
    |
    1 Quiz
  31. Abdominal Compartment Syndrome
    5 Topics
    |
    1 Quiz
  32. Hepatology
    Acute Liver Failure
    5 Topics
    |
    1 Quiz
  33. Portal Hypertension & Variceal Hemorrhage
    5 Topics
    |
    1 Quiz
  34. Hepatic Encephalopathy
    5 Topics
    |
    1 Quiz
  35. Ascites & Spontaneous Bacterial Peritonitis
    5 Topics
    |
    1 Quiz
  36. Hepatorenal Syndrome
    5 Topics
    |
    1 Quiz
  37. Drug-Induced Liver Injury
    5 Topics
    |
    1 Quiz
  38. Dermatology
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    5 Topics
    |
    1 Quiz
  39. Erythema multiforme
    5 Topics
    |
    1 Quiz
  40. Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS)
    5 Topics
    |
    1 Quiz
  41. Immunology
    Transplant Immunology & Acute Rejection
    5 Topics
    |
    1 Quiz
  42. Solid Organ & Hematopoietic Transplant Pharmacotherapy
    5 Topics
    |
    1 Quiz
  43. Graft-Versus-Host Disease (GVHD)
    5 Topics
    |
    1 Quiz
  44. Hypersensitivity Reactions & Desensitization
    5 Topics
    |
    1 Quiz
  45. Biologic Immunotherapies & Cytokine Release Syndrome
    5 Topics
    |
    1 Quiz
  46. Endocrinology
    Relative Adrenal Insufficiency and Stress-Dose Steroid Therapy
    5 Topics
    |
    1 Quiz
  47. Hyperglycemic Crisis (DKA & HHS)
    5 Topics
    |
    1 Quiz
  48. Glycemic Control in the ICU
    5 Topics
    |
    1 Quiz
  49. Thyroid Emergencies: Thyroid Storm & Myxedema Coma
    5 Topics
    |
    1 Quiz
  50. Hematology
    Acute Venous Thromboembolism
    5 Topics
    |
    1 Quiz
  51. Drug-Induced Thrombocytopenia
    5 Topics
    |
    1 Quiz
  52. Anemia of Critical Illness
    5 Topics
    |
    1 Quiz
  53. Drug-Induced Hematologic Disorders
    5 Topics
    |
    1 Quiz
  54. Sickle Cell Crisis in the ICU
    5 Topics
    |
    1 Quiz
  55. Methemoglobinemia & Dyshemoglobinemias
    5 Topics
    |
    1 Quiz
  56. Toxicology
    Toxidrome Recognition and Initial Management
    5 Topics
    |
    1 Quiz
  57. Management of Acute Overdoses – Non-Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  58. Management of Acute Overdoses – Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  59. Toxic Alcohols and Small-Molecule Poisons
    5 Topics
    |
    1 Quiz
  60. Antidotes and Gastrointestinal Decontamination
    5 Topics
    |
    1 Quiz
  61. Extracorporeal Removal Techniques
    5 Topics
    |
    1 Quiz
  62. Withdrawal Syndromes in the ICU
    5 Topics
    |
    1 Quiz
  63. Infectious Diseases
    Sepsis and Septic Shock
    5 Topics
    |
    1 Quiz
  64. Pneumonia (CAP, HAP, VAP)
    5 Topics
    |
    1 Quiz
  65. Endocarditis
    5 Topics
    |
    1 Quiz
  66. CNS Infections
    5 Topics
    |
    1 Quiz
  67. Complicated Intra-abdominal Infections
    5 Topics
    |
    1 Quiz
  68. Antibiotic Stewardship & PK/PD
    5 Topics
    |
    1 Quiz
  69. Clostridioides difficile Infection
    5 Topics
    |
    1 Quiz
  70. Febrile Neutropenia & Immunocompromised Hosts
    5 Topics
    |
    1 Quiz
  71. Skin & Soft-Tissue Infections / Acute Osteomyelitis
    5 Topics
    |
    1 Quiz
  72. Urinary Tract and Catheter-related Infections
    5 Topics
    |
    1 Quiz
  73. Pandemic & Emerging Viral Infections
    5 Topics
    |
    1 Quiz
  74. Supportive Care (Pain, Agitation, Delirium, Immobility, Sleep)
    Pain Assessment and Analgesic Management
    5 Topics
    |
    1 Quiz
  75. Sedation and Agitation Management
    5 Topics
    |
    1 Quiz
  76. Delirium Prevention and Treatment
    5 Topics
    |
    1 Quiz
  77. Sleep Disturbance Management
    5 Topics
    |
    1 Quiz
  78. Immobility and Early Mobilization
    5 Topics
    |
    1 Quiz
  79. Oncologic Emergencies
    5 Topics
    |
    1 Quiz
  80. End-of-Life Care & Palliative Care
    Goals of Care & Advance Care Planning
    5 Topics
    |
    1 Quiz
  81. Pain Management & Opioid Therapy
    5 Topics
    |
    1 Quiz
  82. Dyspnea & Respiratory Symptom Management
    5 Topics
    |
    1 Quiz
  83. Sedation & Palliative Sedation
    5 Topics
    |
    1 Quiz
  84. Delirium Agitation & Anxiety
    5 Topics
    |
    1 Quiz
  85. Nausea, Vomiting & Gastrointestinal Symptoms
    5 Topics
    |
    1 Quiz
  86. Management of Secretions (Death Rattle)
    5 Topics
    |
    1 Quiz
  87. Fluids, Electrolytes, and Nutrition Management
    Intravenous Fluid Therapy and Resuscitation
    5 Topics
    |
    1 Quiz
  88. Acid–Base Disorders
    5 Topics
    |
    1 Quiz
  89. Sodium Homeostasis and Dysnatremias
    5 Topics
    |
    1 Quiz
  90. Potassium Disorders
    5 Topics
    |
    1 Quiz
  91. Calcium and Magnesium Abnormalities
    5 Topics
    |
    1 Quiz
  92. Phosphate and Trace Electrolyte Management
    5 Topics
    |
    1 Quiz
  93. Enteral Nutrition Support
    5 Topics
    |
    1 Quiz
  94. Parenteral Nutrition Support
    5 Topics
    |
    1 Quiz
  95. Refeeding Syndrome and Specialized Nutrition
    5 Topics
    |
    1 Quiz
  96. Trauma and Burns
    Initial Resuscitation and Fluid Management in Trauma
    5 Topics
    |
    1 Quiz
  97. Hemorrhagic Shock, Massive Transfusion, and Trauma‐Induced Coagulopathy
    5 Topics
    |
    1 Quiz
  98. Burns Pharmacotherapy
    5 Topics
    |
    1 Quiz
  99. Burn Wound Care
    5 Topics
    |
    1 Quiz
  100. Open Fracture Antibiotics
    5 Topics
    |
    1 Quiz

Participants 432

  • Allison Clemens
  • April
  • ababaabhay
  • achoi2392
  • adhoward1
Show more
Lesson 99, Topic 1
In Progress

Foundational Principles of Burn Wound Pathophysiology and Risk Factors

Lesson Progress
0% Complete
Foundational Principles of Burn Wound Pathophysiology and Risk Factors

Foundational Principles of Burn Wound Pathophysiology and Risk Factors

Objectives Icon A checkmark inside a circle, symbolizing achieved goals.

Lesson Objective

Summarize the epidemiology and incidence of burn injuries; explain the pathophysiology including barrier loss and systemic inflammation; analyze the impact of chronic comorbidities; and evaluate social determinants of health in risk stratification.

1. Epidemiology and Etiology of Burn Injuries

Burns remain a significant global public health challenge, associated with high mortality and severe long-term morbidity. While domestic and occupational exposures are predominant causes, especially in low-resource settings, the establishment of specialized burn centers has demonstrably improved patient outcomes.

A. Global and National Incidence

  • Global Burden: An estimated 11 million burn injuries occur annually, leading to approximately 180,000 deaths. Over 70% of this burden falls on low- and middle-income countries.
  • U.S. Data: Roughly 400,000 burn-related injuries are treated each year, with about 20,000 requiring admission to specialized burn centers. Access to this specialized care reduces mortality by approximately 30% for major burns.
  • Age Distribution: In high-income countries, incidence peaks in two distinct age groups: toddlers (1–4 years) and adolescents/young adults (10–19 years).

B. Mechanisms and Morbidity

  • Common Mechanisms: Flame burns are the most frequent cause (43%), followed by scalds (34%), electrical injuries (5%), chemical burns (3%), and radiation burns (<1%).
  • Long-term Morbidity: Survivors often face debilitating consequences, including joint contractures, chronic pain, and significant psychosocial sequelae such as PTSD and depression.
Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: The Golden Hours of Transfer

A delay of more than six hours in transferring a patient with major burns to a specialized burn center can double the risk of mortality. Early recognition, prompt stabilization, and rapid referral are critical interventions, particularly in resource-limited regions where initial care capabilities may be constrained.

2. Pathophysiology of Burn Wounds

Thermal injury initiates a cascade of local and systemic events. It disrupts the critical integumentary barrier, unleashes a massive inflammatory response (cytokine storm), induces a profound hypermetabolic state, and, without adequate intervention, can progress to burn shock and multiorgan dysfunction syndrome (MODS).

Jackson’s Burn Wound Model A diagram showing the three concentric zones of a burn injury: the central Zone of Coagulation (irreversible necrosis), the surrounding Zone of Stasis (ischemic but salvageable), and the outer Zone of Hyperemia (inflamed and viable). Zone of Hyperemia Zone of Stasis Zone of Coagulation
Figure 1: The Three Zones of Burn Injury. The central zone of coagulation represents irreversible tissue death. The surrounding zone of stasis is ischemic but potentially salvageable with optimal resuscitation. The outermost zone of hyperemia is inflamed but will recover. The primary goal of early burn care is to preserve the zone of stasis.
  • Barrier Loss: The destroyed epidermis leads to massive transepidermal water and electrolyte losses, impaired temperature regulation, and loss of antimicrobial peptides, creating a portal for microbial colonization and invasion.
  • Local Inflammation: Release of damage-associated molecular patterns (DAMPs) triggers a local inflammatory cascade, with high levels of TNF-α, IL-1, and IL-6 causing profound capillary leakage, tissue edema, and local hypoxia.
  • Systemic Inflammatory Response Syndrome (SIRS): The spillover of these inflammatory cytokines into the systemic circulation causes widespread vasodilation, increased capillary permeability, and a state of relative hypovolemia.
  • Hypermetabolic State: A massive catecholamine surge drives insulin resistance and intense muscle catabolism. This state peaks 7–10 days post-burn and can persist for months, dramatically increasing nutritional requirements.
  • Burn Shock: If resuscitation is inadequate to compensate for the profound fluid shifts, the result is end-organ hypoperfusion, leading to acute kidney injury (AKI), acute respiratory distress syndrome (ARDS), and coagulopathy.
Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Saving the Zone of Stasis

The fate of the zone of stasis determines the ultimate depth and severity of the burn. Interventions such as prompt cooling of the wound (to halt the thermal process) and judicious, balanced fluid resuscitation (to restore perfusion without worsening edema) are critical to preventing the progression of this salvageable tissue to irreversible necrosis.

3. Influence of Pre-existing Chronic Diseases

Chronic comorbidities significantly amplify the risk of infection, graft failure, and mortality in burn patients by impairing perfusion, altering immune function, and exacerbating the metabolic stress response.

Diabetes Mellitus

Diabetes is a major independent risk factor for adverse outcomes. Its impact is multifactorial:

  • It causes pre-existing microvascular dysfunction, which impairs wound healing and perfusion to the zone of stasis.
  • It impairs leukocyte chemotaxis and phagocytosis, increasing susceptibility to infection.
  • Stress-induced hyperglycemia further worsens endothelial injury, immune function, and the risk of both bacterial and fungal infections.

Editor’s Note: A complete chapter would provide detailed coverage on the management of other significant comorbidities, including specific hemodynamic alterations and fluid tolerance in patients with cardiovascular disease, as well as pharmacokinetic changes, nutritional assessment, and renal dosing adjustments for patients with obesity, renal insufficiency, or malnutrition. It would also describe prognostic scoring systems like the Baux score, which integrate age, burn size, and comorbidities to predict mortality.

Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Glycemic Control is Key

Maintaining tight glycemic control with a continuous insulin infusion, targeting a blood glucose level of 140–180 mg/dL, is a critical intervention in diabetic burn patients. This strategy has been shown to halve infectious complications and improve skin graft survival. However, vigilant monitoring is essential to avoid iatrogenic hypoglycemia, which is also associated with poor outcomes.

4. Social Determinants of Health in Burn Patients

Patient outcomes are not solely determined by physiology. Social determinants of health—including access to care, nutrition, health literacy, and socioeconomic factors—significantly influence both the initial risk of injury and the subsequent trajectory of recovery.

Access and Referral Delays

Geographic isolation and transportation barriers can critically delay both initial fluid resuscitation and definitive wound care. Telemedicine protocols are emerging as a valuable tool to improve triage, helping to ensure that patients with large burns (>10% TBSA) or high-risk comorbidities are directed to specialized burn centers without delay.

Socioeconomic and Cultural Factors

Burn incidence is higher in communities with crowded living conditions and where unsafe cooking practices (e.g., open-flame stoves) are common. Furthermore, cultural beliefs or misinformation may cause patients or families to delay seeking care or refuse essential treatments like early surgical excision and grafting.

Editor’s Note: A complete section would further explore the impact of pre-injury nutritional status on outcomes, detailing specific caloric/protein requirements and supplementation strategies. It would also cover the importance of health literacy, including targeted education, addressing language/cultural barriers, and overcoming obstacles to treatment adherence.

Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Prevention Through Education

Public health initiatives are paramount. Community-based education programs that teach simple first aid (e.g., “cool, cover, and call”) and promote the adoption of safer stoves have been shown to reduce the incidence of severe burns by approximately 25% in high-risk regions.

5. Clinical Implications and Risk Stratification

Effective management requires an early, multidimensional assessment that integrates the burn injury itself with patient-specific risk factors. Using burn-specific sepsis screening tools enables prompt intervention and the implementation of tailored preventive strategies.

Key Risk Factors for Mortality

  • Injury Severity: Age > 50 years, presence of an inhalation injury, and full-thickness burns covering > 30% of Total Body Surface Area (TBSA).
  • Comorbidities: Pre-existing diabetes, cardiovascular disease, and obesity are major contributors to poor outcomes.

Sepsis Screening and Biomarkers

Sepsis is a leading cause of death after the initial resuscitation phase. Standard sepsis criteria are often unreliable due to the underlying SIRS state. Burn-specific tools and biomarkers are more effective.

Burn-Specific Sepsis Screening and Key Biomarkers
Category Marker / Tool Threshold / Criteria Clinical Significance
Screening Tool “3 H’s of Burn Sepsis” ≥2 of: Hypoxia, Hypovolemia, Hypo/Hyperthermia Simple bedside trigger for a full sepsis workup and Burn SOFA scoring.
Scoring System Burn SOFA Score Modified SOFA (e.g., hyperglycemia replaces bilirubin) Provides objective organ dysfunction score adapted for the burn patient physiology.
Biomarker Lactate > 2 mmol/L Powerful early predictor of hypoperfusion, resuscitation inadequacy, and mortality.
Biomarker Procalcitonin (PCT) > 1.5 ng/mL (after day 3) Useful for differentiating bacterial infection from baseline SIRS after the acute phase.

The Interdisciplinary Team

Optimal care is delivered by a coordinated, interdisciplinary team. This includes prehospital triage teams, burn surgeons, critical care pharmacists, nutritionists, physical and occupational therapists, and social services. Bundled care approaches that combine early excision and grafting, antimicrobial stewardship, and aggressive metabolic support are central to modern burn management.

References

  1. World Health Organization. Burns Fact Sheet. 2023.
  2. Zhou M, Li Z, Wang C, et al. The epidemiology and trends of burns globally from 1990 to 2019. Burns. 2022;48(1):1-10.
  3. Nielson CB, Duethman NC, Howard JM, et al. Pathophysiology and treatment of inhalation injury. Burns. 2017;43(2):299-307.
  4. Mulder PPG, Vlig M, Boekema BK, et al. Prolonged Local Acute Inflammatory Response in Burn-Injured Skin of Patients Is Associated With Worse Clinical Outcomes. Front Immunol. 2022;13:1034420.
  5. Gibson BHY, Lomas-Neira J, Chung CS, et al. Plasmin drives burn-induced systemic inflammatory response syndrome. J Clin Invest. 2021;131(23):e154439.
  6. Osuka A, Ueyama M. The Systemic Immune Response to Burns. Front Immunol. 2024;15:1156789.
  7. Aldekhayel S, Al-Shehri M, Al-Otaibi F, et al. Clinical outcomes of burn injuries among diabetic patients: A retrospective cohort study. Burns. 2021;47(4):802-808.
  8. Fitzwater J, Purdue GF, Hunt JL, et al. The risk factors and time course of sepsis in the second postburn week. J Trauma. 2003;54(5):959-66.
  9. American Burn Association. American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res. 2007;28(6):776-90.
  10. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-10.
  11. Boehm D, Menke H. Sepsis in Burns—Lessons from Septic Shock Management. Medicina (Kaunas). 2022;58(1):26.
  12. Kamolz LP, Andel H, Schramm W, et al. Lactate: early predictor of morbidity and mortality in patients with severe burns. Burns. 2005;31(8):986-90.
  13. Cabral L, Afreixo V, Santos F, et al. The use of procalcitonin for the diagnosis of sepsis in burn patients: A meta-analysis. Burns. 2017;43(7):1427-1434.
  14. Forjuoh SN. Burns in low- and middle-income countries: A review of the literature. Burns. 2006;32(5):529-37.